Kexing Biopharm Co., Ltd. (688136.SS) SHH

37.02

-1.59(-4.12%)

Updated at October 17 03:00PM

Currency In CNY

Valuation

Market Cap4.3B
Enterprise Value4.64B
P/E Ratio73.38
PEG Ratio0.6
Price/Sales Ratio5.44
Price/Book Ratio4.36
Enterprise/Revenue5.85
Enterprise/EBITDA55.49

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.08

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue1.41B
Revenue/Share6.8
Gross Profit962.73M
EBITDA184.6M
Net Income31.48M
Diluted EPS0.16

Balance Sheet

Total Cash620.97M
Total Cash/Share3.13
Total Debt994.07M
Total Debt/Equity0.59
Current Ratio1.57
Book Value Per Share8.51

Price History

52-Week Change102.18
52-Week High63.99
52-Week Low16.37
Moving Average 50 Days41.62
Moving Average 200 Days35.76

Statistics

Average Volume6.51M
Shares Outstanding198.08M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield0.22
Payout Ratio0.58
Last Split FactorN/A
Last Split DateN/A